2015-2027 Global Ophthalmic Drug Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

March 2020 | 127 pages | ID: 207EB30CCE55EN
Maia Research

Abstracts

The worldwide market for Ophthalmic Drug is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Santen
Merck
Bayer
Ozurdex
Allergan
Valeant
Pfizer
Regeneron
Senju
Roche
Novartis

Major Types Covered
Prescription Drugs
OTC Drugs

Major Applications Covered
Dry Eye Drugs
Retinal Drugs
Infective Drugs
Others

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Ophthalmic Drug Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Ophthalmic Drug Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE OPHTHALMIC DRUG MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL OPHTHALMIC DRUG MARKET-SEGMENTATION BY TYPE

5.1 Prescription Drugs
5.2 OTC Drugs

6 GLOBAL OPHTHALMIC DRUG MARKET-SEGMENTATION BY APPLICATION

6.1 Dry Eye Drugs
6.2 Retinal Drugs
6.3 Infective Drugs
6.4 Others

7 GLOBAL OPHTHALMIC DRUG MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Santen
  8.1.1 Santen Profile
  8.1.2 Santen Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Santen Product/Solution Launches and Enhancements Analysis
  8.1.4 Santen Business Overview/Recent Development/Acquisitions
8.2 Merck
  8.2.1 Merck Profile
  8.2.2 Merck Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Merck Product/Solution Launches and Enhancements Analysis
  8.2.4 Merck Business Overview/Recent Development/Acquisitions
8.3 Bayer
  8.3.1 Bayer Profile
  8.3.2 Bayer Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Bayer Product/Solution Launches and Enhancements Analysis
  8.3.4 Bayer Business Overview/Recent Development/Acquisitions
8.4 Ozurdex
  8.4.1 Ozurdex Profile
  8.4.2 Ozurdex Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Ozurdex Product/Solution Launches and Enhancements Analysis
  8.4.4 Ozurdex Business Overview/Recent Development/Acquisitions
8.5 Allergan
  8.5.1 Allergan Profile
  8.5.2 Allergan Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Allergan Product/Solution Launches and Enhancements Analysis
  8.5.4 Allergan Business Overview/Recent Development/Acquisitions
8.6 Valeant
  8.6.1 Valeant Profile
  8.6.2 Valeant Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Valeant Product/Solution Launches and Enhancements Analysis
  8.6.4 Valeant Business Overview/Recent Development/Acquisitions
8.7 Pfizer
  8.7.1 Pfizer Profile
  8.7.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Pfizer Product/Solution Launches and Enhancements Analysis
  8.7.4 Pfizer Business Overview/Recent Development/Acquisitions
8.8 Regeneron
  8.8.1 Regeneron Profile
  8.8.2 Regeneron Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Regeneron Product/Solution Launches and Enhancements Analysis
  8.8.4 Regeneron Business Overview/Recent Development/Acquisitions
8.9 Senju
  8.9.1 Senju Profile
  8.9.2 Senju Sales, Growth Rate and Global Market Share from 2015-2020
  8.9.3 Senju Product/Solution Launches and Enhancements Analysis
  8.9.4 Senju Business Overview/Recent Development/Acquisitions
8.10 Roche
  8.10.1 Roche Profile
  8.10.2 Roche Sales, Growth Rate and Global Market Share from 2015-2020
  8.10.3 Roche Product/Solution Launches and Enhancements Analysis
  8.10.4 Roche Business Overview/Recent Development/Acquisitions
8.11 Novartis
  8.11.1 Novartis Profile
  8.11.2 Novartis Sales, Growth Rate and Global Market Share from 2015-2020
  8.11.3 Novartis Product/Solution Launches and Enhancements Analysis
  8.11.4 Novartis Business Overview/Recent Development/Acquisitions

9 GLOBAL OPHTHALMIC DRUG MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Ophthalmic Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Ophthalmic Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Ophthalmic Drug Production Analysis from 2015-2020
10.4 North America Ophthalmic Drug Consumption Analysis from 2015-2020
10.5 North America Ophthalmic Drug Import and Export from 2015-2020
10.6 North America Ophthalmic Drug Value, Production and Market Share by Type (2015-2020)
10.7 North America Ophthalmic Drug Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Ophthalmic Drug by Country (United States, Canada)
  10.8.1 North America Ophthalmic Drug Sales by Country (2015-2020)
  10.8.2 North America Ophthalmic Drug Consumption Value by Country (2015-2020)
10.9 North America Ophthalmic Drug Market PEST Analysis

11 EUROPE

11.1 Europe Ophthalmic Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Ophthalmic Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Ophthalmic Drug Production Analysis from 2015-2020
11.4 Europe Ophthalmic Drug Consumption Analysis from 2015-2020
11.5 Europe Ophthalmic Drug Import and Export from 2015-2020
11.6 Europe Ophthalmic Drug Value, Production and Market Share by Type (2015-2020)
11.7 Europe Ophthalmic Drug Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Ophthalmic Drug by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Ophthalmic Drug Sales by Country (2015-2020)
  11.8.2 Europe Ophthalmic Drug Consumption Value by Country (2015-2020)
11.9 Europe Ophthalmic Drug Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Ophthalmic Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Ophthalmic Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Ophthalmic Drug Production Analysis from 2015-2020
12.4 Asia-Pacific Ophthalmic Drug Consumption Analysis from 2015-2020
12.5 Asia-Pacific Ophthalmic Drug Import and Export from 2015-2020
12.6 Asia-Pacific Ophthalmic Drug Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Ophthalmic Drug Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Ophthalmic Drug by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Ophthalmic Drug Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Ophthalmic Drug Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Ophthalmic Drug Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Ophthalmic Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Ophthalmic Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Ophthalmic Drug Production Analysis from 2015-2020
13.4 Latin America Ophthalmic Drug Consumption Analysis from 2015-2020
13.5 Latin America Ophthalmic Drug Import and Export from 2015-2020
13.6 Latin America Ophthalmic Drug Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Ophthalmic Drug Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Ophthalmic Drug by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Ophthalmic Drug Sales by Country (2015-2020)
  13.8.2 Latin America Ophthalmic Drug Consumption Value by Country (2015-2020)
13.9 Latin America Ophthalmic Drug Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Ophthalmic Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Ophthalmic Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Ophthalmic Drug Production Analysis from 2015-2020
14.4 Middle East & Africa Ophthalmic Drug Consumption Analysis from 2015-2020
14.5 Middle East & Africa Ophthalmic Drug Import and Export from 2015-2020
14.6 Middle East & Africa Ophthalmic Drug Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Ophthalmic Drug Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Ophthalmic Drug by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Ophthalmic Drug Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Ophthalmic Drug Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Ophthalmic Drug Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL OPHTHALMIC DRUG MARKET FROM 2020-2027

15.1 Future Forecast of the Global Ophthalmic Drug Market from 2020-2027 Segment by Region
15.2 Global Ophthalmic Drug Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Ophthalmic Drug Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Ophthalmic Drug Market Value ($) and Growth Rate of Ophthalmic Drug from 2015-2027
Global Ophthalmic Drug Production and Growth Rate Segment by Product Type from 2015-2027
Global Ophthalmic Drug Consumption and Growth Rate Segment by Application from 2015-2027
Figure Ophthalmic Drug Picture
Table Product Specifications of Ophthalmic Drug
Table Driving Factors for this Market
Table Industry News of Ophthalmic Drug Market
Figure Value Chain Status of Ophthalmic Drug
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Ophthalmic Drug Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Ophthalmic Drug Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Prescription Drugs of Ophthalmic Drug
Figure OTC Drugs of Ophthalmic Drug
Table Global Ophthalmic Drug Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Ophthalmic Drug Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Dry Eye Drugs of Ophthalmic Drug
Figure Retinal Drugs of Ophthalmic Drug
Figure Infective Drugs of Ophthalmic Drug
Figure Others of Ophthalmic Drug
Table Global Ophthalmic Drug Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Ophthalmic Drug Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Ophthalmic Drug
Figure Online Channel of Ophthalmic Drug
Table Santen Profile (Company Name, Plants Distribution, Sales Region)
Figure Santen Sales and Growth Rate from 2015-2020
Figure Santen Revenue ($) and Global Market Share from 2015-2020
Table Santen Ophthalmic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck Sales and Growth Rate from 2015-2020
Figure Merck Revenue ($) and Global Market Share from 2015-2020
Table Merck Ophthalmic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Bayer Profile (Company Name, Plants Distribution, Sales Region)
Figure Bayer Sales and Growth Rate from 2015-2020
Figure Bayer Revenue ($) and Global Market Share from 2015-2020
Table Bayer Ophthalmic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Ozurdex Profile (Company Name, Plants Distribution, Sales Region)
Figure Ozurdex Sales and Growth Rate from 2015-2020
Figure Ozurdex Revenue ($) and Global Market Share from 2015-2020
Table Ozurdex Ophthalmic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Allergan Profile (Company Name, Plants Distribution, Sales Region)
Figure Allergan Sales and Growth Rate from 2015-2020
Figure Allergan Revenue ($) and Global Market Share from 2015-2020
Table Allergan Ophthalmic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Valeant Profile (Company Name, Plants Distribution, Sales Region)
Figure Valeant Sales and Growth Rate from 2015-2020
Figure Valeant Revenue ($) and Global Market Share from 2015-2020
Table Valeant Ophthalmic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Ophthalmic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Regeneron Profile (Company Name, Plants Distribution, Sales Region)
Figure Regeneron Sales and Growth Rate from 2015-2020
Figure Regeneron Revenue ($) and Global Market Share from 2015-2020
Table Regeneron Ophthalmic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Senju Profile (Company Name, Plants Distribution, Sales Region)
Figure Senju Sales and Growth Rate from 2015-2020
Figure Senju Revenue ($) and Global Market Share from 2015-2020
Table Senju Ophthalmic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Roche Profile (Company Name, Plants Distribution, Sales Region)
Figure Roche Sales and Growth Rate from 2015-2020
Figure Roche Revenue ($) and Global Market Share from 2015-2020
Table Roche Ophthalmic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis Sales and Growth Rate from 2015-2020
Figure Novartis Revenue ($) and Global Market Share from 2015-2020
Table Novartis Ophthalmic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Ophthalmic Drug Production Value ($) by Region from 2015-2020
Table Global Ophthalmic Drug Production Value Share by Region from 2015-2020
Table Global Ophthalmic Drug Production by Region from 2015-2020
Table Global Ophthalmic Drug Consumption Value ($) by Region from 2015-2020
Table Global Ophthalmic Drug Consumption by Region from 2015-2020
Table North America Ophthalmic Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Ophthalmic Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Ophthalmic Drug Import and Export from 2015-2020
Table North America Ophthalmic Drug Value ($) by Type (2015-2020)
Table North America Ophthalmic Drug Production by Type (2015-2020)
Table North America Ophthalmic Drug Consumption by Application (2015-2020)
Table North America Ophthalmic Drug Consumption by Country (2015-2020)
Table North America Ophthalmic Drug Consumption Value ($) by Country (2015-2020)
Figure North America Ophthalmic Drug Market PEST Analysis
Table Europe Ophthalmic Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Ophthalmic Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Ophthalmic Drug Import and Export from 2015-2020
Table Europe Ophthalmic Drug Value ($) by Type (2015-2020)
Table Europe Ophthalmic Drug Production by Type (2015-2020)
Table Europe Ophthalmic Drug Consumption by Application (2015-2020)
Table Europe Ophthalmic Drug Consumption by Country (2015-2020)
Table Europe Ophthalmic Drug Consumption Value ($) by Country (2015-2020)
Figure Europe Ophthalmic Drug Market PEST Analysis
Table Asia-Pacific Ophthalmic Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Ophthalmic Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Ophthalmic Drug Import and Export from 2015-2020
Table Asia-Pacific Ophthalmic Drug Value ($) by Type (2015-2020)
Table Asia-Pacific Ophthalmic Drug Production by Type (2015-2020)
Table Asia-Pacific Ophthalmic Drug Consumption by Application (2015-2020)
Table Asia-Pacific Ophthalmic Drug Consumption by Country (2015-2020)
Table Asia-Pacific Ophthalmic Drug Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Ophthalmic Drug Market PEST Analysis
Table Latin America Ophthalmic Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Ophthalmic Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Ophthalmic Drug Import and Export from 2015-2020
Table Latin America Ophthalmic Drug Value ($) by Type (2015-2020)
Table Latin America Ophthalmic Drug Production by Type (2015-2020)
Table Latin America Ophthalmic Drug Consumption by Application (2015-2020)
Table Latin America Ophthalmic Drug Consumption by Country (2015-2020)
Table Latin America Ophthalmic Drug Consumption Value ($) by Country (2015-2020)
Figure Latin America Ophthalmic Drug Market PEST Analysis
Table Middle East & Africa Ophthalmic Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Ophthalmic Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Ophthalmic Drug Import and Export from 2015-2020
Table Middle East & Africa Ophthalmic Drug Value ($) by Type (2015-2020)
Table Middle East & Africa Ophthalmic Drug Production by Type (2015-2020)
Table Middle East & Africa Ophthalmic Drug Consumption by Application (2015-2020)
Table Middle East & Africa Ophthalmic Drug Consumption by Country (2015-2020)
Table Middle East & Africa Ophthalmic Drug Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Ophthalmic Drug Market PEST Analysis
Table Global Ophthalmic Drug Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Ophthalmic Drug Production and Growth Rate Forecast by Region (2020-2027)
Table Global Ophthalmic Drug Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Ophthalmic Drug Production and Growth Rate Forecast by Type (2020-2027)
Table Global Ophthalmic Drug Consumption and Growth Rate Forecast by Application (2020-2027)